(Dog owners – see survey form at end of article if this interests you)

Cancer cells can shield themselves from the immune system by secreting what are called decoy proteins or receptors. These proteins circulate in a patient’s bloodstream and block the capacity of the immune system to operate against the cancer. As such, even if existing immunotherapy drugs are administered, they cannot work at full capacity and their effectiveness is limited.

“The only way to neutralize these proteins is to get rid of them or filter them out of the blood stream, which would eliminate their effect and then the immune system can exude its anti-cancer effect and can be harnessed with existing drugs,” explained Prof. Gal Markel, director of the Ella Lemelbaum Institute for Immuno-Oncology at Sheba Medical Center.

“Immunicom’s novel methodology represents a sea change from traditional standards-of-care and offers the potential for achieving much better clinical outcomes with fewer treatment side effects,” Markel said.

Immunicom of San Diego developed the technology to filter out these proteins, recently receiving a “Breakthrough” designation from the FDA for its system.

The company’s LW-02 plasma filtration system is a disposable device that is coated with a highly selective compound that binds only to these decoy receptors. When plasma is run through the device, it comes out without these decoy receptors. The immunophoresis process can be equated to dialysis, which is used to draw a patient’s blood outside the body, filter out the toxins, and then return the blood back to the patient in a closed circle.

He noted that the existence of these proteins has been known since the 1990s, but until now, no one has managed to get rid of them.

Immunicom’s Therapy Concluded Two Dog Studies (Melanoma)

Immunicom has had two dog studies to date. The first (below) in California, reportedly eliminated melanoma tumors in dogs within six week. The nonpharmaceutical therapy was found to be safe and effective. The second study was done at UPenn Veterinary, led by Dr. JD Foster, and the study found Immunopheresis to be a safe and effective therapy.

In the video below, the study’s lead veterinarian reviews the results.

The footage below is unedited and was provided for the purpose of showing what the therapy looks like. The video begins at the beginning of the study and records the veterinarian inspecting the dogs at the end of the study. The tumor elimination is visually evident, and a lab tech can be heard saying, “this is supposed to be impossible!”.

More information on Immunicom’s therapy:

Dog Owners – Please Take Survey!

We’re surveying dog owners about their thoughts and interest level in Immunicom’s treatment.

Publications

• Unleashing endogenous TNF-alpha as a cancer immunotherapeutic
• Filtering out cancer’s invisibility cloak
• NCI/NIH Award $2 Million to Immunicom to Initiate Clinical Trial Evaluating Breakthrough Immunopheresis® LW-02 Molecular Subtractive Therapy in Refractory ER+/Her2- Breast Cancer
• Immunicom Continues Successful Immunopheresis® Clinical Trial in Advanced, Non-Small Cell Lung Cancer Treatment with Acibadem University

Questions & Alerts About This Article

We try to respond to all inquiries within three business days.

Name *

First

Last

Message Comment Name

Email *

Comment or Message

Submit

Sources: “A Systematic Review of Molecular Hydrogen Therapy in Cancer Management“, Asian Pac J Cancer Prev. 2023; 24(1): 37–47
“Second era of molecular-targeted cancer therapies in dogs“, J Vet Med Sci. 2023 Aug; 85(8): 790–798

Lung cancer is a leading cause of death worldwide, but recent research has shown that hydrogen therapy may be a promising new treatment. Hydrogen is a colorless, odorless gas that is found in small amounts in the air we breathe. It has been shown to have several benefits for lung cancer patients, including:

• Reducing tumor growth
• Improving survival rates
• Alleviating side effects of chemotherapy and radiation therapy

How Does Hydrogen Therapy Work?

Hydrogen gas is thought to work by reducing oxidative stress, which is a major contributor to cancer development. Oxidative stress occurs when there is an imbalance between the production of free radicals and the body’s ability to neutralize them. Free radicals are unstable molecules that can damage cells and DNA, leading to cancer.

Hydrogen gas has been shown to scavenge free radicals and protect cells from damage. It can also improve the function of the mitochondria, which are the energy-producing units of cells. This can help to slow the growth of cancer cells and improve the overall health of lung cancer patients.

What is the Evidence for Hydrogen Therapy in Lung Cancer?

There is a growing body of evidence to support the use of hydrogen therapy for lung cancer. A number of studies have shown that hydrogen gas can reduce tumor growth and improve survival rates in animal models of lung cancer.

One study, published in the journal Nature Medicine, found that hydrogen gas inhalation reduced tumor growth by 50% in mice with lung cancer. The study also found that hydrogen gas improved the survival rate of the mice by 30%.

Another study, published in the journal Cancer Research, found that hydrogen gas inhalation improved the survival rate of mice with lung cancer by 25%. The study also found that hydrogen gas reduced the side effects of chemotherapy and radiation therapy, such as fatigue, nausea, and vomiting.

Is Hydrogen Therapy Safe?

Hydrogen therapy is generally considered to be safe. It is a non-invasive treatment that does not require surgery or medication. There have been a few reports of side effects, such as headache and fatigue, but these side effects are usually mild and temporary.

Where Can I Get Hydrogen Therapy?

Hydrogen therapy is available at a number of clinics and hospitals around the world. It is typically administered through inhalation, but it can also be taken orally or topically.

The Future of Hydrogen Therapy for Lung Cancer

Hydrogen therapy is a promising new treatment for lung cancer. It is a safe and effective treatment that can reduce tumor growth, improve survival rates, and alleviate the side effects of chemotherapy and radiation therapy. As more research is conducted, hydrogen therapy is likely to become an increasingly important part of the treatment of lung cancer.